Related Experiment Videos
Concomitant and alternating radiation therapy (RT) and chemotherapy (CT) for inoperable, M0, non-small cell lung
R O Mirimanoff1, P Rubin, J D Cox
1Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne, Switzerland.
Lung Cancer (Amsterdam, Netherlands)
|November 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict.
Journal of cancer policy·2022
International multidisciplinary expert panel consensus on breast reconstruction and radiotherapy.
The British journal of surgery·2019
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES.
Breast cancer research and treatment·2017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
First-line camrelizumab plus chemotherapy followed by camrelizumab-apatinib maintenance for ES-SCLC: a single-arm phase II study.
Lung cancer (Amsterdam, Netherlands)·2026
Standard targeted therapy implementation for driver alterations newly identified by comprehensive genomic profiling in clinically driver-negative advanced NSCLC.
Lung cancer (Amsterdam, Netherlands)·2026
Discordance in pleural mesothelioma response classification and modelling of impact on clinical trials.
Lung cancer (Amsterdam, Netherlands)·2026
Reassessing surgical resection in small cell lung cancer in the multimodal treatment era.
Lung cancer (Amsterdam, Netherlands)·2026
Characterization of the genomic and transcriptomic landscape of invasive non-mucinous lung adenocarcinoma based on IASLC grading.
Lung cancer (Amsterdam, Netherlands)·2026
Molecular concordance and clonal dynamics of KRAS mutations in lung adenocarcinoma across distinct clinical scenarios.
Lung cancer (Amsterdam, Netherlands)·2026